can glp 1 and dpp4 be used together dpp-4 inhibitors glp-1 agonists Cardiovascular effects of the DPP-4 inhibitors Frontiers | DPP-4 Inhibitors as

[4] [7] NICE provides guidance on their use within the NHS, typically recommending them when other treatments have not achieved adequate glycaemic control or weight management goals

Dose adjustment is required in moderate-to-severe renal impairment and in moderate hepatic impairment, and the medication is not recommended in severe hepatic impairment or end-stage renal disease

Consultation fees often apply

The question of whether semaglutide directly causes pancreatitis remains an area of ongoing investigation, with current evidence suggesting a possible association rather than a confirmed causal relationship

doi: 10.1016/j.ebiom.2015.05.022 6 HanahanDWeinbergRA